Effective Hydration-Centered Management of Acute Gastroenteritis in a 13-Year-Old Patient: Insights from Primary Care Practice
Abstract
Acute gastroenteritis remains one of the most common acute conditions in children and adolescents, frequently leading to dehydration and requiring prompt clinical assessment to prevent further complications. Although management guidelines are well established, variability in presentation and progression highlights the importance of individualized and holistic diagnostic approaches in primary care. This report describes a case involving a 13-year-old male who presented with severe gastrointestinal symptoms, including diarrhea exceeding ten episodes per day over three consecutive days, more than five episodes of vomiting, abdominal pain, fever, and generalized weakness. Clinical examination demonstrated a weakened overall condition, blood pressure of 100/70 mmHg, pulse 85 beats per minute, respiratory rate 20 breaths per minute, temperature 36.7°C, and signs consistent with mild to moderate dehydration. Laboratory evaluation revealed slightly decreased leukocyte levels, suggesting a likely viral etiology. The management in this case reflects the methodological core of the intervention: a holistic, stepwise approach integrating intravenous rehydration, symptomatic therapy, and adaptive pharmaceutical adjustments based on evolving clinical features. The patient was administered Ringer’s Lactate intravenously through a loading dose followed by controlled infusion at 25 drops per minute. Antiemetic therapy with ondansetron, antipyretics, antacids, attapulgite, and oral rehydration…
Read the paper
Related studies
- Patient-Centered Pharmaceutical Design to Improve Acceptability of Medicines: Similarities and Differences in Paediatric and Geriatric Populations
- Evidence-based clinical practice guidelines for irritable bowel syndrome 2020
- Phase 2b Study of Pimodivir (JNJ-63623872) as Monotherapy or in Combination With Oseltamivir for Treatment of Acute Uncomplicated Seasonal Influenza A: TOPAZ Trial
- Gastrointestinal manifestations in COVID-19
- COVID-19 and Gastrointestinal Disease: Implications for the Gastroenterologist
- Persistent gut barrier damage and commensal bacterial influx following eradication of Giardia infection in mice
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.